Article Name Asia Pacific
IceCure Medical Seeks Israeli Regulatory Approval for Next-Gen XSense™ Cryoablation System
Building on FDA clearance, IceCure files for Israeli approval of its XSense™ System, expanding minimally invasive cryoablation solutions across multiple medical specialties in line with the growing trend of surgical de-escalation.
25th February, 2025
South Korea’s PranaQ Secures FDA Clearance for AI-Powered Sleep Apnea Wearable, Backed by NAVER D2SF
With FDA 510(k) clearance for TipTraQ, PranaQ is set to transform home-based sleep diagnostics. The AI-driven wearable, supported by NAVER D2SF, delivers clinical-grade sleep and respiratory insights, ensuring accessible, multi-night testing and seamless remote monitoring. With FDA 510(k) clearance for TipTraQ, PranaQ is set to transform home-based sleep diagnostics. The AI-driven wearable, supported by NAVER D2SF, delivers clinical-grade sleep and respiratory insights, ensuring accessible, multi-night testing and seamless remote monitoring.
21st February, 2025
NaviFUS Leverages Taiwan’s Advanced Chip Technology to Advance Non-Invasive Brain Disorder Treatments
With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators.
20th February, 2025
Thailand’s BNH Hospital Achieves 100% Paperless Transformation with InterSystems TrakCare, Setting a New Benchmark in Digital Healthcare
Investing in change management, BNH Hospital drives full clinician adoption of TrakCare EMR, enhancing data-driven decision-making and patient care in Thailand’s evolving healthcare landscape.
19th February, 2025
Philips and SingHealth Partner to Accelerate AI-Driven Digital Healthcare Transformation in Singapore
Strategic collaboration aims to enhance patient care by integrating AI and predictive data management, streamlining imaging workflows, and optimizing ICU capacity, with full implementation targeted by 2028.
19th February, 2025
NX Taiwan Secures TFDA Certification for Medical Device Quality Management—A First for a Japanese Company
Nippon Express (Taiwan) Co., Ltd. earns medical device QMS certification for its NEXT3 warehouse in Taoyuan, reinforcing its capabilities in compliant storage, packaging, and labeling of medical devices to meet Taiwan’s stringent quality control standards.
17th February, 2025
XPOVIO® Gains Public Health Insurance Coverage in Taiwan
Antengene expands access for patients with relapsed/refractory multiple myeloma.
14th February, 2025
MedTech Catapult Launches at Biopolis to Boost Singapore’s MedTech Innovation
Dr Tan See Leng officiates the launch, introducing a vital directory to connect MedTech innovators with trusted local manufacturing partners, marking a new era for Singapore’s MedTech ecosystem.
13th February, 2025
NEOM Invests in Paradromics to Advance Neurotechnology
Partnership drives innovation in brain-computer interfaces for healthcare.
13th February, 2025
Bangkok Dusit Medical Services Partners with CNN to Tackle Global Health Challenges
Collaboration aims to explore next-gen healthcare solutions through innovation and global insights.
11th February, 2025
“Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly”
2024 saw Japanese medtech firm Olympus receiving approval for the company’s first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”. The estimated revenue and annual growth rate during the fiscal year ending March 2025 of Olympus Corporation is approximately 1,009 billion yen/ 9 per cent. To find out more about the company’s strategic growth plans in the new year, BioSpectrum Asia interacted with Marc Radatt, Chief Executive Officer of Olympus Corporation Asia Pacific, Singapore.
03rd February, 2025
“There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility”
Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region. The platform enables HCPs to share clinical experiences, and engage in secure, peer-to-peer discussions. Docquity uses AI/ML to provide insights into HCP preferences, shaping personalised healthcare engagement strategies for enterprises. In an interview with BioSpectrum, Amit Vithal, Co-founder and Chief of Growth, Docquity discusses key trends in digital health across Asia, Docquity’s expansion into government healthcare initiatives, how the company’s data-driven approach is transforming healthcare engagement and shaping future B2G collaborations across Asia.
03rd February, 2025
Malaysia Turns Key Med Tourism Hub
Malaysia is emerging as a prominent medical tourism hub, with the sector generating revenue of $444 million (RM 2 billion) in 2023. A combination of factors is driving this growth such as including strong government support and strategic private-sector partnerships. Let's explore further.
03rd February, 2025
DRG Launches Innovative TBI Test Panel at MEDLAB Dubai
The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities.
03rd February, 2025
Madhya Pradesh Chief Minister Showcases Ujjain’s Medical Device & Pharma Park to Japanese Investors in Tokyo, Positioning MP Among India’s Leading Industrial States
Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.
29th January, 2025
Expecto Health Science Partners with Indonesia’s Mayapada Healthcare to Advance Clinical Research in Asia-Pacific
Strategic MOU signed to expand high-quality, agile clinical trial services in Indonesia, fostering regional growth and collaboration for impactful therapeutic solutions.
23rd January, 2025
Lepu Biopharma grants ArriVent exclusive license for MRG007 ADC
Promising treatment for gastrointestinal cancers aims to set new standards in precision oncology.
22nd January, 2025
SBC Medical launches specialized Medical Aesthetics Translation App
Pioneering a New Era Where Global Patients Can Embrace Beauty and Confidence Through Japan's Cutting-Edge Medical Aesthetics
21st January, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer